1.
J Pediatr
; 243: 208-213.e3, 2022 04.
Article
in English
| MEDLINE
| ID: mdl-34952008
ABSTRACT
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.